Warfarin pharmacogenetics: economic considerations.
Hughes
Dyfrig A
DA
Pirmohamed
Munir
M
D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use*; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D003365:Costs and Cost Analysis; D065729:Cytochrome P-450 CYP2C9; D006801:Humans; D010597:Pharmacogenetics; D014859:Warfarin / Q000191:economics* / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases